Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 80 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

ESICON 2012 KOLKATA MINI-REVIEW

New options for the medical treatment of Cushing's syndrome

Trainer Peter J

Year : 2013| Volume: 17| Issue : 2 | Page no: 245-248

   This article has been cited by
 
1 UPDATE ON THE CLINICOPATHOLOGY OF PITUITARY ADENOMAS
Chung Thong Lim,Márta Korbonits
Endocrine Practice. 2018; 24(5): 473
[Pubmed]  [Google Scholar] [DOI]
2 The Role of Isotretinoin Therapy for Cushing’s Disease: Results of a Prospective Study
Lucio Vilar,José Luciano Albuquerque,Ruy Lyra,Erik Trovão Diniz,Frederico Rangel Filho,Patrícia Gadelha,Ana Carolina Thé,George Robson Ibiapina,Barbara Sales Gomes,Vera Santos,Maíra Melo da Fonseca,Karoline Frasão Viana,Isis Gabriella Lopes,Douglas Araújo,Luciana Naves
International Journal of Endocrinology. 2016; 2016: 1
[Pubmed]  [Google Scholar] [DOI]
3 Medical combination therapies in Cushing’s disease
Lucio Vilar,Luciana A. Naves,Márcio C. Machado,Marcello D. Bronstein
Pituitary. 2015;
[Pubmed]  [Google Scholar] [DOI]
4 Therapeutic strategies for Cushing’s syndrome: an update
Filippo Ceccato,Mattia Barbot,Marialuisa Zilio,Nora Albiger,Franco Mantero,Carla Scaroni
Expert Opinion on Orphan Drugs. 2015; 3(1): 45
[Pubmed]  [Google Scholar] [DOI]

 

Read this article